Industry reports
Editor highlights

Search inside this page

All regions

Free Market Research Guides to Download

Pharmaceutical Analysis & Statistics in Japan, May 2012 (p30)

You might be interested in: therapeutics, cancer, drug, more »

» Purchase Premium Reports

871-900 of about 1 800 reports
Drug and Medication in United States: Gilead Sciences, Inc. ? Product Pipeline Review - H2 2011

Drug and Medication in United States: Gilead Sciences, Inc. ? Product Pipeline Review - H2 2011

  • $ 500
  • Company report
  • May 2012
  • by Global Markets Direct

- Product Pipeline Review - H2 2011? provides a detailed overview on the Gilead Sciences, Inc.?s research and development focus. The report includes data on current developmental pipeline, complete with ...

  • Industries : Drug and Medication
  • Countries : Japan, United States
Health Statistics : Trigeminal Neuralgia - The disease is not as rare as previously thought

Health Statistics : Trigeminal Neuralgia - The disease is not as rare as previously thought

  • $ 5 700
  • Industry report
  • May 2012
  • by Datamonitor

This module provides an estimate of the number of diagnosed incident and total prevalent cases of trigeminal neuralgia in the seven major industry s using historical trends for the disease and underlying ...

  • Industries : Pathology
  • Countries : Germany, Spain, Italy, France, Japan, United States, United Kingdom, Europe, World
Insulin - Japan

Insulin - Japan

  • $ 652
  • Industry report
  • May 2012
  • by Global Research & Data Services

This market research report offers a perspective on the actual market situation, trends and future outlook for insulin in Japan. The study provides essential market information for decision-makers including: ...

  • Industries : Drug and Medication
  • Countries : Japan
Insulin - Top 5 Asian Markets

Insulin - Top 5 Asian Markets

  • $ 2 514
  • Industry report
  • May 2012
  • by Global Research & Data Services

This market research report package offers an in-depth perspective on the actual market situation, trends and future outlook for insulin in top 5 Asian markets. The analyses provide essential market information ...

  • Industries : Drug and Medication
  • Countries : Asia, South Korea, Indonesia, Japan, India, China, World
BioGaia AB: Ingredients Company Profile, SWOT & Financial Report

BioGaia AB: Ingredients Company Profile, SWOT & Financial Report

  • $ 125
  • Company report
  • May 2012
  • by Canadean Ltd

Product Synopsis Canadean's "BioGaia AB: Ingredients Company Profile, SWOT & Financial Report" contains in depth information and data about the company and its operations. The profile contains a company ...

  • Industries : Vitamin and Supplement
  • Countries : United States, Sweden, Japan
Health Statistics : Chronic Lower Back Pain - Millions will continue to be out of work over the next decade

Health Statistics : Chronic Lower Back Pain - Millions will continue to be out of work over the next decade

  • $ 5 700
  • Industry report
  • May 2012
  • by Datamonitor

About This Report In 2010, Datamonitor estimates that there were about 55.7 million total prevalent cases of chronic low back pain in people aged 18 and over in the seven major industry s (the US, Japan, ...

  • Industries : Pathology
  • Countries : Japan, Spain, Italy, France, Germany, United Kingdom, Europe, United States, World
Shionogi Inc.: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report

Shionogi Inc.: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report

  • $ 125
  • Company report
  • May 2012
  • by ICD Research

Synopsis ICD Research's "Shionogi Inc.: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report" contains in depth information and data about the company and its operations. The profile ...

  • Industries : Pharmaceutical
  • Countries : Japan
Global Angiongenesis Inhibitors and Stimulators Industry

Global Angiongenesis Inhibitors and Stimulators Industry

  • $ 4 950
  • Industry report
  • May 2012
  • by Global Industry Analyst

This report analyzes the worldwide markets for Angiogenesis Inhibitors and Stimulators in US$ Million by the following Product Segments: Angiogenesis Inhibitors, and Angiogenesis Stimulators. Annual estimates ...

  • Industries : Drug and Medication
  • Countries : World, United States, Europe, Japan
Takeda Pharmaceutical Firms Limited SWOT

Takeda Pharmaceutical Firms Limited SWOT

  • $ 175
  • Company report
  • May 2012
  • by MarketLine

examines the firm ?s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy. Takeda Pharmaceutical (Takeda) is the largest pharmaceutical ...

  • Industries : Pharmaceutical
  • Countries : Japan
AAB-001 (bapineuzumab) (Alzheimer's disease) - Analysis and Forecasts to 2022

AAB-001 (bapineuzumab) (Alzheimer's disease) - Analysis and Forecasts to 2022

  • $ 2 000
  • Industry report
  • April 2012
  • by Global Data

AAB-001 (bapineuzumab) (Alzheimer's disease) - Analysis and Forecasts to 2022 Summary GlobalData's pharmaceuticals report, ?AAB-001 (bapineuzumab) (Alzheimer's disease) - Analysis and Forecasts to 2022? ...

  • Industries : Pathology
  • Countries : United States, World, Japan, Spain, Italy, France, Germany, Europe, United Kingdom
Exelon (Alzheimer's disease) - Analysis and Forecasts to 2022

Exelon (Alzheimer's disease) - Analysis and Forecasts to 2022

  • $ 2 000
  • Industry report
  • April 2012
  • by Global Data

Exelon (Alzheimer's disease) - Analysis and Forecasts to 2022 Summary GlobalData's pharmaceuticals report, ?Exelon (Alzheimer's disease) - Analysis and Forecasts to 2022? provides Exelon global sales ...

  • Industries : Pathology
  • Countries : World, Japan, United States, Spain, Italy, France, Germany, Europe, United Kingdom
Aricept (Alzheimer's disease) - Analysis and Forecasts to 2022

Aricept (Alzheimer's disease) - Analysis and Forecasts to 2022

  • $ 2 000
  • Industry report
  • April 2012
  • by Global Data

Aricept (Alzheimer's disease) - Analysis and Forecasts to 2022 Summary GlobalData's pharmaceuticals report, ?Aricept (Alzheimer's disease) - Analysis and Forecasts to 2022? provides Aricept global sales ...

  • Industries : Pathology
  • Countries : Japan, United States, World
LY2062430 (Alzheimer's disease) - Analysis and Forecasts to 2022

LY2062430 (Alzheimer's disease) - Analysis and Forecasts to 2022

  • $ 2 000
  • Industry report
  • April 2012
  • by Global Data

LY2062430 (Alzheimer's disease) - Analysis and Forecasts to 2022 Summary GlobalData's pharmaceuticals report, ?LY2062430 (Alzheimer's disease) - Analysis and Forecasts to 2022? provides LY2062430 global ...

  • Industries : Pathology
  • Countries : World, United States, Japan, Spain, Italy, France, Germany, Europe, United Kingdom
Namenda (Alzheimer's disease) - Analysis and Forecasts to 2022

Namenda (Alzheimer's disease) - Analysis and Forecasts to 2022

  • $ 2 000
  • Industry report
  • April 2012
  • by Global Data

Namenda (Alzheimer's disease) - Analysis and Forecasts to 2022 Summary GlobalData's pharmaceuticals report, ?Namenda (Alzheimer's disease) - Analysis and Forecasts to 2022? provides Namenda global sales ...

  • Industries : Pathology
  • Countries : World, United States, Japan, Spain, Italy, France, Germany, Europe, United Kingdom
Pathology: Obsessive Compulsive Disorder (OCD) Therapeutics

Pathology: Obsessive Compulsive Disorder (OCD) Therapeutics

  • $ 3 995
  • Industry report
  • April 2012
  • by Global Data

GlobalData, the market analysis specialist, has released its new report, ??. The report is an essential source of information and analysis on the global Obsessive-Compulsive Disorder (OCD) Therapeutics ...

  • Industries : Therapy
  • Countries : Japan, Germany, United States, Spain, Italy, France, World, Europe, United Kingdom
Neuroendocrine Carcinoma Therapeutics - Pipeline Assessment and Market Forecast to 2019

Neuroendocrine Carcinoma Therapeutics - Pipeline Assessment and Market Forecast to 2019

  • $ 3 995
  • Company report
  • April 2012
  • by Global Data

Neuroendocrine Carcinoma Therapeutics - Pipeline Assessment and Market Forecast to 2019 Summary GlobalData, the industry analysis specialist, has released its new report, ?Neuroendocrine Carcinoma Therapeutics ...

  • Industries : Therapy
  • Countries : Japan, Spain, France, Italy, Germany, United States, United Kingdom, Europe, World
Health Statistics : Breakthrough Cancer Pain - Explosion of pain due to Market Overview in creased cancer Market Overview in cidence

Health Statistics : Breakthrough Cancer Pain - Explosion of pain due to Market Overview in creased cancer Market Overview in cidence

  • $ 5 700
  • Industry report
  • April 2012
  • by Datamonitor

Global cancer incidence is increasing rapidly, with about 12.4 million cases in 2008. In the next 50 years, cancer incidence will rise globally, driven by aging populations and a rise in risk factors. ...

  • Industries : Pathology
  • Countries : Spain, Germany, Italy, France, Japan, World, Europe, United States, United Kingdom
World Pathology: Dyspepsia - Pipeline Review, H1 2012

World Pathology: Dyspepsia - Pipeline Review, H1 2012

  • $ 500
  • Company report
  • April 2012
  • by Global Markets Direct

This report provides data on the therapeutic development for Dyspepsia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...

  • Industries : Pathology
  • Countries : World, Japan
Research Case : Autism Spectrum Disorders - Public awareness and physician detailing will drive industry growth

Research Case : Autism Spectrum Disorders - Public awareness and physician detailing will drive industry growth

  • $ 1 900
  • Industry report
  • April 2012
  • by Datamonitor

To date, only two products have gained approval for the treatment of ASDs; Risperdal (risperidone; Johnson & Johnson) and Abilify (aripiprazole; Bristol-Myers Squibb/Otsuka Pharmaceuticals) are both approved ...

  • Industries : Pathology
  • Countries : United States, Japan
Global Biosimilars Industry

Global Biosimilars Industry

  • $ 4 500
  • Industry report
  • April 2012
  • by Global Industry Analyst

This report analyzes the worldwide markets for Biosimilars in US$ Million. The report provides separate comprehensive analytics for US, Europe, and Japan. Annual estimates and forecasts are provided fo ...

  • Industries : Generic Drug
  • Countries : World, India, Europe, United States, Japan, France, Germany, Asia, United Kingdom, North America
Matsumotokiyoshi Holdings Co., Ltd.: Retailing Company Profile, SWOT & Financial Report

Matsumotokiyoshi Holdings Co., Ltd.: Retailing Company Profile, SWOT & Financial Report

  • $ 125
  • Company report
  • April 2012
  • by Canadean Ltd

Synopsis Canadean's "Matsumotokiyoshi Holdings Co., Ltd.: Retailing Company Profile, SWOT & Financial Report" contains in depth information and data about the company and its operations. The profile contains ...

  • Industries : Pharmacies and Drug Stores, E-commerce
  • Countries : Japan
Rheumatoid Arthritis Drugs Market in Japan 2011-2015

Rheumatoid Arthritis Drugs Market in Japan 2011-2015

  • $ 1 500
  • Industry report
  • April 2012
  • by Infiniti Research Limited

TechNavio's analysts forecast the Rheumatoid Arthritis market in Japan to grow at a CAGR of 29.2 percent over the period 2011-2015. One of the key factors contributing to this market growth is the high ...

  • Industries : Drug and Medication
  • Countries : Japan
Anti-cancer Drugs Market in Japan 2011-2015

Anti-cancer Drugs Market in Japan 2011-2015

  • $ 1 500
  • Industry report
  • April 2012
  • by Infiniti Research Limited

TechNavio's analysts forecast the Anti-cancer Drugs market in Japan to grow at a CAGR of 11.1 percent over the period 2011-2015. One of the key factors contributing to this market growth is the increase ...

  • Industries : Drug and Medication
  • Countries : Japan
Pharmaceuticals Market Overview in Japan Market Overview in

Pharmaceuticals Market Overview in Japan Market Overview in

  • $ 599
  • Industry report
  • April 2012
  • by Mintel

Pharmaceuticals in Japan by Mintel Global Industry Navigator provides you with annual year-end industry size figures, most recently updated in 2011. This industry includes prescription and OTC pharmaceuticals. ...

  • Industries : Pharmaceutical
  • Countries : Japan
Orphan Drugs in Asia 2012: Guidelines and Regulatory Requirements to Help Orphan Drug Products Enter the Asian Market 2012

Orphan Drugs in Asia 2012: Guidelines and Regulatory Requirements to Help Orphan Drug Products Enter the Asian Market 2012

  • $ 1 500
  • Industry report
  • April 2012
  • by Pacific Bridge Medical

Historically, many drugs for rare diseases were developed to fulfill the needs of public health, rather than for drug companies' financial gain. Nevertheless, there is now a growing awareness of rare diseases ...

  • Industries : Drug and Medication
  • Countries : Asia, Japan, Taiwan, South Korea, China, World, Philippines, Singapore, Malaysia, United States, Vietnam, Thailand
Contract Research Organizations in Asia 2012

Contract Research Organizations in Asia 2012

  • $ 1 500
  • Industry report
  • April 2012
  • by Pacific Bridge Medical

Overview: This report on Asian CROs provides a comprehensive list of contract research organizations in Asia. The countries covered include: Japan, Taiwan, Korea, Singapore, Hong Kong, India, China, Malaysia, ...

  • Industries : Drug Discovery and Development
  • Countries : Asia, Philippines, Singapore, Indonesia, Vietnam, Thailand, Taiwan, South Korea, Malaysia, Japan, India, China, World
Guidelines and Regulatory Requirements to Help Orphan Drug Products Enter the Asian Market

Guidelines and Regulatory Requirements to Help Orphan Drug Products Enter the Asian Market

  • $ 1 500
  • Industry report
  • April 2012
  • by Pacific Bridge Medical

Overview: Following the example of the US FDA's Orphan Drug Act established in 1983, some Asian countries have developed orphan drug legislations, such as Singapore's Orphan Drug Exemption to the Medicines ...

  • Industries : Drug and Medication
  • Countries : Asia, Japan, South Korea, Taiwan, China, World, Philippines, Singapore, United States, Malaysia
Shionogi & Co., Ltd. SWOT

Shionogi & Co., Ltd. SWOT

  • $ 175
  • Company report
  • April 2012
  • by MarketLine

examines the firm ?s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy. Shionogi is a pharmaceutical group specialized in ...

  • Industries : Prescription Drug
  • Countries : Japan
MarketVIEW - Staphylococcus aureus vaccines

MarketVIEW - Staphylococcus aureus vaccines

  • $ 9 995
  • Industry report
  • April 2012
  • by VacZine Analytics Group Of Assay Advantage Ltd

Gram-positive Staphylococcus aureus is an opportunistic pathogen and a major cause of patient morbidity and mortality, especially in "at risk" populations. The organism can cause a wide range of infections ...

  • Industries : Drug and Medication
  • Countries : United States, France, Germany, Europe, Australia, Canada, United Kingdom, Spain, Italy, Japan, World
Votrient (Renal Cell Carcinoma) - Analysis and Forecasts to 2022

Votrient (Renal Cell Carcinoma) - Analysis and Forecasts to 2022

  • $ 2 000
  • Industry report
  • March 2012
  • by Global Data

Votrient (Renal Cell Carcinoma) - Analysis and Forecasts to 2022 Summary GlobalData's pharmaceuticals report, ?Votrient (Renal Cell Carcinoma) - Analysis and Forecasts to 2022? provides Votrient sales ...

  • Industries : Pathology
  • Countries : World, Japan, United States, Spain, Italy, France, Germany, United Kingdom, Europe

» Read our Company Profiles

32 Companies

Icon Group

United States

GlaxoSmithKline P.L.C.

United States

Novartis Inc.

Switzerland

Johnson and Johnson

United States

GlaxoSmithKline PLC

United Kingdom

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.